FDA approves IND for clinical trial evaluating CBD-based drug January 25, 2022 Auto Bot Clinical Development 0 The agency has given the go-ahead on an IND application for a study evaluating Ananda Scientificâs Nantheia ATL5, a candidate for treating opioid use disorder.
